These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18822228)

  • 1. [Global spread of meningococcal serogroup W135].
    Vestergård D; David KP
    Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of meningococcal disease and the impact of vaccines.
    Khatami A; Pollard AJ
    Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012.
    Parent du Chatelet I; Barboza P; Taha MK
    Euro Surveill; 2012 May; 17(21):. PubMed ID: 22687826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.
    von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K;
    Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningitis epidemics in Africa: a brief overview.
    Teyssou R; Muros-Le Rouzic E
    Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular surveillance of meningococcal meningitis in Africa.
    Caugant DA; Nicolas P
    Vaccine; 2007 Sep; 25 Suppl 1():A8-11. PubMed ID: 17521785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
    Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
    Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
    Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
    Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal disease and travel.
    Memish ZA
    Clin Infect Dis; 2002 Jan; 34(1):84-90. PubMed ID: 11731951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travel-related Neisseria meningitidis serogroup W135 infection, France.
    Taha MK; Kacou-N'douba A; Hong E; Deghmane AE; Giorgini D; Okpo SL; Kangah T; Dosso M
    Emerg Infect Dis; 2013 Jun; 19(6):1030-2. PubMed ID: 23735310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningitis control in countries of the African meningitis belt, 2015.
    Wkly Epidemiol Rec; 2016 Apr; 91(16):209-16. PubMed ID: 27108455
    [No Abstract]   [Full Text] [Related]  

  • 17. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.